Society guideline links: Medication-related osteonecrosis of the jaw

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Osteonecrosis".)

International

●Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)/American Society of Clinical Oncology (ASCO): Clinical practice guideline on medication-related osteonecrosis of the jaw (2019)

●International Task Force on ONJ: Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management (2017)

Canada

●Canadian Association of Oral and Maxillofacial Surgeons (CAOMS): Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw (2008)

United States

●American Association of Oral and Maxillofacial Surgeons (AAOMS): Position paper on medication-related osteonecrosis of the jaw, update (2022)

●Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)/American Society of Clinical Oncology (ASCO): Clinical practice guideline on medication-related osteonecrosis of the jaw (2019)

●American Association of Endodontists (AAE): Guideline on endodontic implications of medication-related osteonecrosis of the jaw (2018)

●American Academy of Oral Medicine (AAOM): Clinical practice statement on the use of serum C-terminal telopeptide cross-link of type 1 collagen (CTX) testing in predicting risk of osteonecrosis of the jaw (ONJ) (2017)

Japan

●Japanese Allied Committee on Osteonecrosis of the Jaw: Position paper on antiresorptive agent-related osteonecrosis of the jaw (2017)